Aicuris’s pritelivir is forecast to be a significant advancement for immunocompromised patients with refractory HSV ...

Innovative Molecules' adibelivir had a favourable pharmacokinetic profile and proved safe and efficacious in Phase I clinical ...

Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced multiple presentations at the 2026 American ...

A video of Uttar Pradesh police assaulting women surfaced on social media in the backdrop of violent protests in Noida over ...

Recurrent respiratory infections and a mediastinal mass prompted evaluation and diagnosis of Good syndrome — a ...

Awareness Month. The purpose is to promote knowledge about the impact of STIs, reduce stigma and promote testing and ...

Mikey Moore is having himself a heck of a season on loan at Rangers. The 18-year-old Tottenham Hotspur winger is flying at ...

A 13-year-old boy with no history presented after 4 days of progressively worsening whole body rash.Nine days before ...

Sanofi and Regeneron’s Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria ...

As temperatures soar, so do cases of conjunctivitis, commonly known as pink eye. There is a seasonal spike, driven by heat, ...

A drug long used to fight cancer may soon take on a very different role. Researchers at the University of Illinois Chicago ...